© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Orgenesis Acquires Cell Therapy Manufacturer MaSTherCell for USD25m
Posted 12th March 2015

Orgenesis Acquires Cell Therapy Manufacturer MaSTherCell for USD25m

NULL

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Orgenesis Acquires Cell Therapy Manufacturer MaSTherCell for USD25m
Image

Orgenesis Acquires Cell Therapy Manufacturer MaSTherCell for USD25m

Orgenesis Inc., a leader in the emerging fields of cellular therapy and re-generative medicine for the treatment of Type 1 Diabetes, today announced the Company’s plan to increase its global presence and capabilities by acquiring MaSTherCell, an emerging pioneer in the industrialization of cell-based therapeutics, based in Gosselies, Belgium.  

Orgenesis entered into a share exchange agreement with MaSTherCell SA and Cell Therapy Holding SA (collectively “MaSTherCell”) and each of the shareholders of the MaSTherCell, which provides for the acquisition by the Company of all of the issued and outstanding shares of MaSTherCell in exchange for the issuance of $24,593,000 in value of shares of common stock in the capital of the Company.

“The acquisition of MaSTherCell creates incremental value for both companies in business-critical ways.  First, it allows us to accelerate the transition of our lead product, Autologous Insulin Producing Cells (AIPCs) being developed as a therapeutic for Type 1 Diabetes, from pre-clinical testing into clinical trials.  Second, the acquisition will also allow us to diversify our business model and future product offering,” said Vered Caplan, chairperson and CEO of Orgenesis.  “We are creating a vertically integrated company that will deliver more end-user value and generate a stronger financial position for our overall business.  Both businesses will remain operationally independent, but will become strategically aligned in ways that maximize technical, financial and management synergies.  As a result of the acquisition, Orgenesis benefits from deeper involvement in the manufacturing process and resulting cost of goods efficiencies, while MaSTherCell benefits by expanding its international presence and by gaining access to public markets and financing for further technology-based investment.”

Orgenesis is an innovator in the technology of “cellular trans-differentiation.”  This process involves re-programming one adult cell type to function like an adult cell of a different type.  In the case of AIPCs, the company is transforming a type 1 diabetic patient’s own liver cells into insulin-producing cells. Cellular trans-differentiation is accomplished through a complex biologic process, requiring sophisticated manufacturing technology and capabilities.  MaSTherCell has in place a best-in-class combination of the process development capabilities and fully closed and tightly controlled GMP systems required to deliver commercial-scale manufacturing for Orgenesis.  Prior to the acquisition, the two companies have already been working together under a strategic manufacturing agreement.  With the acquisition in place, MaSTherCell will provide services not only to Orgenesis, but will continue to provide broad Contract Development and Manufacturing Services to other cell-based therapeutic companies around the world.

“Cell therapy developments have gained strategic significance in recent years – particularly in the areas of regenerative medicine, ex-vivo gene therapy and immunotherapy of cancer,” said Hugues Bultot, CEO of MaSTherCell.  “Research and scientific development in these sectors has seen rapid progress and because of our ability to innovate, our industrialization and manufacturing expertise has not only kept pace with, but has actually led in terms of the ability of our technology to meet the needs of rapidly evolving science.  Moving forward with Orgenesis, we will continue to provide for our current clients the same unique services but with a larger geographic reach.  By combing our organizations, we will be able to more quickly capitalize on our desires to expand our cell-based therapeutic contract development and manufacturing services internationally.  And, importantly, having access to public markets will enhance our ability to invest in the continued evolution of our technology and capabilities.”

For more information about either company, please visit www.orgenesis.com and www.masthercell.com

Categories: Finance, M&A


You Might Also Like
Read Full PostRead - Eye Icon
Injury at Work; What to Do If You Get Hurt on the Job
News
17/06/2024Injury at Work; What to Do If You Get Hurt on the Job

Injury at Work; What to Do If You Get Hurt on the Job Suffering an injury at work can be a tough situation, not just physically but emotionally and financially too. Knowing the right steps to take after getting injured on the job is crucial to ensure you get t

Read Full PostRead - Eye Icon
Hogan Lovells Advise Mapfre’s Acquisition of Direct Line
Finance
30/07/2015Hogan Lovells Advise Mapfre’s Acquisition of Direct Line

Hogan Lovells Advise Mapfre's Acquisition of Direct Line

Read Full PostRead - Eye Icon
BGF announces further investment in SPEX Group Holdings Limited
Finance
24/01/2019BGF announces further investment in SPEX Group Holdings Limited

Aberdeen-headquartered SPEX Group Holdings Limited (“SPEX Group”) has secured a multi-million pound follow-on investment from its management team and BGF, the UK’s most active investor in growing businesses, to accelerate growth. BGF originally invested

Read Full PostRead - Eye Icon
How Smart Management Tools Enhance Business Scalability
Innovation
16/08/2024How Smart Management Tools Enhance Business Scalability

Scaling a business can feel like juggling too many balls at once. The good news is smart management tools are here to lend a hand, offering solutions that simplify growth. Picture navigating uncharted waters with the right technology compass – these inno

Read Full PostRead - Eye Icon
Accountancy Firms Must Evolve and Innovate to Survive Says ICAEW
Finance
17/03/2015Accountancy Firms Must Evolve and Innovate to Survive Says ICAEW

The accountancy landscape is changing – new technologies, competition, regulations and client expectations are making the future of the profession uncertain, says ICAEW.

Read Full PostRead - Eye Icon
A Spotlight on Insolvency & Restructuring
Legal
05/10/2015A Spotlight on Insolvency & Restructuring

Solomon Harris was founded in 1998 by Managing Partner Sophia Harris. With offices in central George Town, the capital of the Cayman Islands, and Zurich, Switzerland, the firm offers cost effective legal advice to both local and international clients wishing t

Read Full PostRead - Eye Icon
Principle Networks Partners with Global Cybersecurity Expert Arctic Wolf
M&A
27/06/2024Principle Networks Partners with Global Cybersecurity Expert Arctic Wolf

Network services provider Principle Networks has announced a new partnership with Arctic Wolf, an industry-leading managed detection and response service, to help proactively protect its customers against advanced cyberattacks.

Read Full PostRead - Eye Icon
Founders Need To Think Differently About M&A Exits, Says Investment Bank CEO
M&A
09/07/2024Founders Need To Think Differently About M&A Exits, Says Investment Bank CEO

50% of M&A deals fail because most approaches to exit involve hiring an M&A banker and marketing the business for sale.

Read Full PostRead - Eye Icon
How To Process ABA Claims: A Step-By-Step Guide
News
23/10/2023How To Process ABA Claims: A Step-By-Step Guide

Ensure ABA claims are processed timeously with our guide. Understanding how to process ABA claims for healthcare professionals, medical staff, and private individuals is essential in the operating field of behavioural health. Because Applied Behaviour Analysis



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow